Trinity Biotech (TRIB) Debt Ratio (2009 - 2025)

Trinity Biotech (TRIB) posted Debt Ratio of 0.0 for Q2 2025, up 3.67% sequentially from 0.0 in Q4 2024, and down 5.3% YoY from 0.0 in Q2 2024.

Trinity Biotech (TRIB) Debt Ratio (2009 - 2025) Analysis & Trends

Trinity Biotech has reported Debt Ratio for 15 years, with the latest figure at 0.0 in Q2 2025.

Quarterly Debt Ratio fell 5.3% year-over-year to 0.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was 0.0 (down 5.3% YoY) and the FY2024 annual result came in at 0.0, down 42.46% from the prior year.
Debt Ratio improved to 0.0 in Q2 2025 per TRIB's latest filing, from 0.0 in the prior quarter.
Over five years, Debt Ratio peaked at 1.4 in Q4 2021 and troughed at 0.0 in Q3 2022.
A 5-year average of 0.27 and a median of 0.0 in 2025 frame the typical range for Debt Ratio.
The sharpest annual moves came in 2022 and 2023: Debt Ratio sank 99.84% in 2022, then soared 209.93% in 2023.
Over 5 years, Debt Ratio stood at 1.4 in 2021, then sank by 99.84% to 0.0 in 2022, then jumped by 209.93% to 0.01 in 2023, then plunged by 42.46% to 0.0 in 2024, then gained by 3.67% to 0.0 in 2025.
According to Business Quant data, Debt Ratio over the past three periods registered 0.0, 0.0, and 0.0 for Q2 2025, Q4 2024, and Q3 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	200.79 Bn	195.19 Bn	7.27 Bn	0.30
2	Stryker	125.96 Bn	122.49 Bn	4.50 Bn	0.31
3	Medtronic	118.43 Bn	109.21 Bn	6.41 Bn	0.30
4	Boston Scientific	73.13 Bn	72.59 Bn	3.85 Bn	0.28
5	Edwards Lifesciences	51.63 Bn	47.38 Bn	1.35 Bn	0.04
6	Dexcom	34.60 Bn	32.65 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.71 Bn	31.60 Bn	2.18 Bn	0.27
8	Koninklijke Philips	26.17 Bn	22.85 Bn	4.55 Bn	0.28
9	Steris	23.14 Bn	22.66 Bn	684.20 Mn	0.18
10	Trinity Biotech	6.96 Mn	1.82 Mn	-	-

Download Data